Beyond weight loss: multisystem benefits of obesity medications, The Lancet Diabetes & Endocrinology, 14 , 8, (678-692), (2026)
Another phase III, randomized, open-label, non-inferiority, head-to-head trial, AWARD-6, evaluated dulaglutide (1.5 mg) versus liraglutide (1.8 mg) in patients with T2DM
Ten pounds later and I feel so much better." STL Medical Weight Loss program For years I felt stuck and overwhelmed about my weight
Quick Answer: Tirzepatide and vitamin B3 (niacin) can be taken together as no direct drug interaction exists, but concurrent use requires enhanced glucose monitoring due to their opposing effects on blood sugar metabolism
Once the body exposed to oxidative stress, these GSH are doubled and make GSSG, which are oxidized states
The medication is a tool, not a replacement for good nutrition